Roche Xeloda Phase III Trial To Look At Combo Therapy with Docetaxel
Executive Summary
Roche is planning a Phase III trial for Xeloda (capecitabine) that will compare the product in combination with Rhone-Poulenc Rorer's Taxotere (docetaxel) against docetaxel monotherapy.